Viewing a single comment thread. View all comments

biggerarmsthanyou t1_iudvlgm wrote

Ok, more DD please. Biotech stocks are incredibly risky, at any price. I want you to explain trial data, where it’s going, and all of that stuff. I care about money, and business. It doesn’t matter what a company claims to do, they need to be able to execute.

2

LocalMerchant67 OP t1_iufhk3r wrote

Executive summary. They have been working on getting this perfect since they were Axax (AVRT) long ago. Key scientist joined forces with an repentant ex-hedge fund manager and they are now BioVaxys. They bought and brought rights from the former company. Patents are in place. It’s called “haptenization”. Essentially, bonding the right proteins with haptens and going after cancer tumours, COVID and related viruses all with the same technology. In trials now for both. They hope to finish proving their ability to tackle all pansarbecoviruses and will have results shortly. Look up their Twitter account and as you scroll you’ll see the gist of what they are working on and also some photos and results of tumour shrinkage. If you want even more, I’d be happy to share if you have a question. I’m truly stoked about this as much as an investor as hoping for some solutions to our society’s worst health problems. I own 1% of the OS of the company so it’s not a joke or some sort of pump to me. It’s the real deal/

1